Method for the Detection of Dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs
The invention describes a new method for the detection of dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs. HDL from patients with mild to severe CKD, is specifically associated with a component of human blood plasma which alters the endothelial effects of HDL. This novel pathomechanism leads to a HDL phenotype promoting hypertension and likely accelerating atherosclerosis even in incipient CKD that may contribute to elevated cardiovascular morbidity and mortality.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…
